Literature DB >> 6300713

Cation transport in erythrocytes of patients with renal failure.

F Zannad, R J Royer, M Kessler, B Huriet, J Robert.   

Abstract

Na+, K+-ATPase activity in erythrocytes (RBC) has been assessed indirectly by the 86Rb uptake method in 10 patients with acute renal failure (ARF), 11 patients with chronic renal failure (CRF) on haemodialysis and 13 patients treated by kidney transplantation, and compared to age-matched healthy controls. In each patients, the sensitivity of 86Rb uptake to digoxin (IC50) has been measured. Na+, K+-ATPase activity was decreased in patients with ARF and in patients with CRF but not in transplanted patients. IC50 was lowered in transplanted patients. The implications of these findings are discussed in terms of possible mechanisms of the changes in Na+, K+-ATPase activity in RBC of patients with renal failure.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6300713     DOI: 10.1159/000182877

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  Membrane ATPase, erythrocyte sodium and potassium in haemodialysis patients.

Authors:  J Solski; A Ksiazek; S Szymonik-Lesiuk; Z Marzec
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

2.  Abnormal cation transport in uremia. Mechanisms in adipocytes and skeletal muscle from uremic rats.

Authors:  W Druml; R A Kelly; R C May; W E Mitch
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

3.  Erythrocyte sodium transport in dialyzed uremic patients.

Authors:  Y S Yoon; S Y Kim; W S Koo; E J Choi; Y S Chang; B K Bang; H R Moon
Journal:  Korean J Intern Med       Date:  1989-01       Impact factor: 2.884

Review 4.  Erythrocyte Deformability and Na,K-ATPase Activity in Various Pathophysiological Situations and Their Protection by Selected Nutritional Antioxidants in Humans.

Authors:  Jana Radosinska; Norbert Vrbjar
Journal:  Int J Mol Sci       Date:  2021-11-03       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.